BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $15
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $12 to $15.
BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $12 to $15.